{"filing":{"accession_number":"0001213900-26-073847","cik":"0001844417","ticker":"ESLAW","company_name":"Estrella Immunopharma, Inc.","form":"8-K","filing_date":"2026-06-30","report_date":null,"primary_document":"ea029661701-8k_estrella.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1844417/000121390026073847/ea029661701-8k_estrella.htm"},"events":[{"id":15115,"run_id":13482,"accession_number":"0001213900-26-073847","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a clear disclosure of shareholder vote results from the Combined 2025/2026 Annual Meeting of Stockholders held on June 29, 2026. The filing reports the final voting results for Proposal 1 (ratification of Macias Gini \u0026 O'Connell LLP as independent auditor), with 30,351,203 votes for, 400 against, and 5 abstentions, resulting in approval. This is a routine but material shareholder vote disclosure required under Item 5.07.","company_name":"Estrella Immunopharma, Inc.","ticker":"ESLAW","filing_date":"2026-06-30","form":"8-K","submitted_at":null,"items":[{"id":12758,"accession_number":"0001213900-26-073847","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from the Combined 2025/2026 Annual Meeting of Stockholders held on June 29, 2026. The filing reports the final voting results for Proposal 1 (ratification of Macias Gini \u0026 O'Connell LLP as independent auditor), with 30,351,203 votes for, 400 against, and 5 abstentions, resulting in approval. This is a routine but material shareholder vote disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T02:30:16.741838+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12758,"accession_number":"0001213900-26-073847","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from the Combined 2025/2026 Annual Meeting of Stockholders held on June 29, 2026. The filing reports the final voting results for Proposal 1 (ratification of Macias Gini \u0026 O'Connell LLP as independent auditor), with 30,351,203 votes for, 400 against, and 5 abstentions, resulting in approval. This is a routine but material shareholder vote disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T02:30:16.741838+00:00","company_name":"Estrella Immunopharma, Inc.","ticker":"ESLAW","filing_date":"2026-06-30"}]}